ATHENS, Greece–(BUSINESS WIRE)–Piraeus Bank S.A. (ATHEX: TPEIR) (OTCQX: BPIRY) (OTCQX: BPIRF):
FY.25: 16% RoaTBV, Ethniki Insurance acquisition completed, payout ratio increased to 55%
- €1.2bn normalized profit | €1.1bn on a reported basis, as guided; beat on revenues, with strong finish in Q4
- €0.82 EPS after AT1 coupon | Exceeding guidance of €0.80 for the year, fully absorbing the fast decumulation of base rates
- €40c per share cash dividend | On top of €100mn share buyback executed in Q4; €592mn total distribution out of 2025, 7% total yield
- €3.9bn net credit expansion | Europe-leading +11% loan growth yoy, with pricing discipline maintained; €0.3bn net credit expansion in retail
- 33% cost-to-core income ratio | Best-in-class efficiency ratio confirming cost discipline, despite inflation and ongoing investments
- €0.7bn revenues from services | Best-in-class in Greece; 0.82% fees over assets, 26% revenues from services out of total revenues
- €2.7bn net revenues | Revenues from services up 7%; NII up qoq, marking prior quarter as the trough
- 52bps organic CoR | NPE ratio at 2.0%, NPE coverage at 73% vs 65% a year ago
- +27% AuM yoy | €14.5bn AuM; €1.5bn net inflows in 2025; deposits at €66bn, up €3.2bn, +5% yoy, funding 90% of credit expansion
- 18.7% total capital ratio | Buffer of c.275bps above P2G, CET1 ratio at 12.7%; MREL at 29.0% with c.165bps buffer above requirement
Contacts
PressOffice@piraeusbank.gr
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact
crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.